#ALUR hashtag - Bluesky

Allurion Advances Plan to Regain Listing Compliance Allurion (OTCID: ALUR) has appealed the New York Stock Exchange decision to initiate delisting proceedings under Section 802.01B, which requires a 30-day average global market capitalization of at least $15,000,000. The company plans to regain NYSE compliance or relist on the NYSE American after its FDA approval of the Allurion Gastric Balloon System on February 20, 2026.Allurion says it will strengthen the balance sheet and fund U.S. commercialization; securities currently trade on the OTCID market while the plan is executed. No assurance of success was stated.

2 weeks ago

#ALUR Allurion Advances Plan to Regain Listing Compliance

www.stocktitan.net/news/ALUR/allurion-advan...

0 0 0 0

Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy Allurion (OTCID: ALUR) has begun U.S. training and on-boarding of partner accounts and started manufacturing its FDA-approved product, with first shipments expected in April 2026. The launch targets patients who started then stopped GLP-1s and explores employer partnerships to broaden benefit coverage.The company expects U.S. availability to expand through 2026 as additional partners complete training and begin offering the Allurion Program in clinical settings nationwide.

2 weeks ago

#ALUR Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy

www.stocktitan.net/news/ALUR/allurion-begin...

0 0 0 0

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE Allurion (NYSE: ALUR) received a NYSE notice initiating delisting proceedings for failure to meet Section 802.01B listing standards. The company intends to appeal and expects its common stock to continue trading on the NYSE during the review.Allurion cited FDA approval on February 20, 2026 as the first step in a plan to regain compliance or relist, and referenced creditor negotiations, a previously announced debt-for-preferred exchange agreement, and a warrant inducement completed February 24, 2026 as part of its remediation efforts.

3 weeks ago

#ALUR Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

www.stocktitan.net/news/ALUR/allurion-inten...

0 0 0 0

Weight-loss tech firm behind a smart capsule sees sales jump to end 2025 Allurion projects Q4 revenue of $3.3M–$3.7M, up 22%–37% from Q3, with full-year 2025 revenue near $15M and substantial cuts to operating expenses and loss.

2 months ago

#ALUR Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

GLOBAL Visibility aéPiot - by aePiot.ro

@globalvisibility.bsky.social

2 months ago

From Zero to Monopoly: The Asymmetric Warfare of Organic Network Dominance. How Platform Economics Creates Winner-Take-All Markets Without Traditional Competition. From Zero to Monopoly: The Asymmetric Warfare of Organic Network Dominance How Platform Economics Creates Winner-Take-All Markets Without...

better-experience.blogspot.com/2026/01/from...

#ACEH
headlines-world.com/advanced-sea...
#ALUR #MUNANG #BENDAHARA #ACEH #TAMIANG
headlines-world.com/advanced-sea...
#DEHIDROEPIANDROSTERON
multi-search-tag-explorer.allgraph.ro/advanced-sea...
aepiot.ro

0 0 0 0

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence Allurion Technologies, Inc., a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low-dose tirzepatide therapy to optimize muscle mass and GLP-1 adherence. 76 patients treated with the Allurion Smart Capsule were started on low-dose tirzepatide after completing their first 45...

4 months ago

#ALUR Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

Viral! Saiko Wow Banget, Endingnya Malah Jadi Anjing #Terviral - #Video #pendek yang #viral bertajuk “#Saiko”, yang #sukses bikin #netizen #tercengang dengan #alur #ceritanya yang tak terduga. Video berdurasi singkat ini tiba-tiba menjadi trending di berbagai platform seperti TikTok, X (Twitter), dan Instagram Reels. Yang paling bikin ramai? Ending-nya benar-benar bikin melongo — karakter utamanya malah berubah jadi anjing! Baca: Viral! Masuk Dikit Eh Langsung Nembak, Ceweknya Heboh dan Penasaran…

4 months ago

#ALUR Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

Topoin

@topoin.bsky.social

5 months ago

Viral! Saiko Wow Banget, Endingnya Malah Jadi Anjing

#Terviral - #Video #pendek yang #viral bertajuk “#Saiko”, yang #sukses bikin #netizen #tercengang dengan #alur #ceritanya yang tak terduga. Video berdurasi singkat ini tiba-tiba menjadi trending di berbagai platform seperti TikTok, X (Twitter),…

0 1 0 0

22.1% Avg Weight Loss — Allurion Smart Capsule delivers surgery‑level results in 121 adults across 11 sites Peer‑reviewed multicenter study: two consecutive Allurion Smart Capsule treatments achieved 22.1% TBWL (19.3 kg) in 121 adults across 11 sites; no serious device‑related AEs; PMA module submitted.

5 months ago

#ALUR Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

Les Ecologistes Paris 5

@lesecolosparis5.bsky.social

6 months ago

Barre Cassan Paris 5e - RIVP Plus de 580 logements pour étudiants seront notamment créés grâce à cette réhabilitation menée par la RIVP.

Plus simplement, la loi #ALUR (2014) prévoit une #compensation: pour 1m² de logement détruit, 3m² doivent être créés dans le même arrond. Les m² de logements transformés en hôtel ne sont possibles que parce qu'on a créé AU MOINS 3X plus de m² de logements à #Paris5 • 🧵2/4 www.rivp.fr/projets/barr...

2 1 1 0

PostgreSQL

@postgresql.activitypub.awakari.com.ap.brid.gy

6 months ago

2rZiKKbOU3nTafniR2qMMSE0gwZ

Belajar Automasi Cerdas dengan N8N: Solusi Fleksibel untuk Alur Kerja Anda Di era digital yang serba cepat, efisiensi adalah kunci. Bayangkan jika Anda bisa mengotomatiskan tugas-tugas repetitif ya...

#abdul #aziz #ahwan #ai #ai #workflow #alur #kerja #artificial #intelligence #n8n

Origin | […]

0 0 0 0

@2rzikkbou3ntafnir2qmmse0gwz.activitypub.awakari.com.ap.brid.gy

6 months ago

2rZiKKbOU3nTafniR2qMMSE0gwZ

Belajar Automasi Cerdas dengan N8N: Solusi Fleksibel untuk Alur Kerja Anda Di era digital yang serba cepat, efisiensi adalah kunci. Bayangkan jika Anda bisa mengotomatiskan tugas-tugas repetitif ya...

#abdul #aziz #ahwan #ai #ai #workflow #alur #kerja #artificial #intelligence #n8n

Origin | […]

0 0 0 0

@2rzikkbou3ntafnir2qmmse0gwz.activitypub.awakari.com.ap.brid.gy

6 months ago

2rZiKKbOU3nTafniR2qMMSE0gwZ

Belajar Automasi Cerdas dengan N8N: Solusi Fleksibel untuk Alur Kerja Anda Di era digital yang serba cepat, efisiensi adalah kunci. Bayangkan jika Anda bisa mengotomatiskan tugas-tugas repetitif ya...

#abdul #aziz #ahwan #ai #ai #workflow #alur #kerja #artificial #intelligence #n8n

Origin | […]

0 0 0 0

@2rzikkbou3ntafnir2qmmse0gwz.activitypub.awakari.com.ap.brid.gy

6 months ago

Revolutionizing Workforce Dynamics: WorkWhile's 'Unemployment is Dead' Campaign Takes Off WorkWhile launches an innovative campaign, 'Unemployment is Dead,' showcasing the American Labor Utilization Rate (ALUR) to redefine workforce potential and economic prosperity.

Belajar Automasi Cerdas dengan N8N: Solusi Fleksibel untuk Alur Kerja Anda Di era digital yang serba cepat, efisiensi adalah kunci. Bayangkan jika Anda bisa mengotomatiskan tugas-tugas repetitif ya...

#abdul #aziz #ahwan #ai #ai #workflow #alur #kerja #artificial #intelligence #n8n

Origin | […]

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

6 months ago

Revolutionizing Workforce Dynamics: WorkWhile's 'Unemployment is Dead' Campaign Takes Off #USA #San_Francisco #WorkWhile #ALUR #flexible_workforce

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

7 months ago

Leading Indicators, Tuesday August 19, 2025 – Crystal Equity Research

Small-cap stocks with declining money flow, Tue Aug 19th - #LOCO #JRVR #GNLN #DTSS #CELU #BCAl #AZ #ZIM #WEAV #TSE #KURA #HUMA #FLWS #SFL #IPI #GPRK #FINV #CHGG #CGC #ALUR #STKL #VNET #TBHC - More: crystalequityresearch.com/leading-indi... - #smallcap

0 0 0 0

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update Allurion Technologies (NYSE:ALUR) reported Q2 2025 financial results and announced a strategic pivot focusing on low-dose GLP-1 combination therapy. Revenue was $3.4 million, down from $11.8 million in Q2 2024, primarily due to distributor transitions. The company reported a reduced operating loss of $7.0 million, a 26% improvement year-over-year.Key developments include a strategic partnership for manufacturing and R&D, including potential development of a GLP-1 drug-eluting balloon, and FDA acceptance of their Pre-Market Authorization application. The company ended Q2 with $12.7 million in cash and is implementing a restructuring plan expected to cost $1.5 million in Q3 2025.The company also disclosed a potential financial restatement related to non-cash items concerning Revenue Interest Financing Agreement and convertible notes calculations.

7 months ago

#ALUR Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update

www.stocktitan.net/news/ALUR/allurion-repor...

0 0 0 0

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry Allurion Technologies (NYSE:ALUR) announced a strategic pivot focusing on low-dose GLP-1 combination therapy and muscle mass maintenance. The company has signed a term sheet with a strategic partner for expanding distribution and R&D, including potential development of a novel GLP-1 drug-eluting balloon.Key developments include: submission of a protocol for a multi-center trial combining Allurion Program with low-dose GLP-1s, transition to distribution partners with GLP-1 prescription networks, and FDA acceptance of PMA application. Real-world data from 20,000 patients shows successful weight loss maintenance and muscle mass increases. Clinics piloting the combination approach grew 20% QoQ in Q2 2025.Preliminary Q2 2025 results show $3 million revenue and $7 million operating loss, with operating expenses reduced by 50% YoY.

7 months ago

#ALUR Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

Clinical Studies: Allurion Patients Keep Off 32 Pounds One Year After Treatment New research reveals long-term success of AI-powered weight loss program across 1,000+ patients. See breakthrough maintenance rates and clinical outcomes. Learn more.

8 months ago

#ALUR Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

8 months ago

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with improving money flow, Wed Jul 9th - #XLO #TAOX #SBC #RAIL #PAHC #OABI #KALA #INBX #GSIT #CNXN #AZTA #LDI #GGT #DK #CPUH #BGR #ALUR - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss Allurion Technologies (NYSE:ALUR) has announced a strategic distribution partnership with Minogue Medical Inc. in Canada to advance metabolically healthy weight loss solutions. The partnership leverages Minogue Medical's 40-year experience and extensive network of dietitians, bariatric surgeons, and endoscopic specialists across Canada.The collaboration aims to increase access to the Allurion Program combined with GLP-1 therapy, focusing on sustainable weight loss while maintaining muscle mass. Minogue Medical's established infrastructure and expertise in bariatric and obesity care will help implement Allurion's approach through a medically supervised, evidence-based framework.

8 months ago

#ALUR Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

Allurion's Revolutionary Weight Loss Balloon Achieves 4.34% Superior Weight Loss in Pivotal FDA Trial Final FDA submission reveals Allurion's weight loss balloon exceeded key endpoints with 4.34% superior weight reduction vs control. See complete trial insights.

8 months ago

#ALUR Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0

Major Weight Loss Breakthrough: 20,000 Patient Study Reveals Muscle-Preserving Success of Allurion Program Latest clinical data from 20,000 patients shows sustained weight loss while preserving muscle mass with AI-powered gastric balloon. See 4-year outcomes data.

9 months ago

#ALUR Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS

www.stocktitan.net/news/ALUR/allurion-annou...

0 0 0 0